Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Additional risk factors commonly present in patients prescribed GLP-1 receptor agonists include: Reduced physical activity and prolonged immobility Hypertension and other cardiovascular comorbidities Dyslipidaemia contributing to atherosclerosis Advanced age , as thrombotic risk increases with ageing Other important VTE risk factors include: Previous VTE or family history of clotting disorders Thrombophilia (inherited or acquired clotting disorders) Active cancer or cancer treatment Oestrogen-containing medications (HRT, combined oral contraceptives) Pregnancy and postpartum period Recent surgery, trauma or hospitalisation Long-haul travel with prolonged immobility Smoking When patients taking GLP-1 receptor agonists experience thrombotic events, it is important to consider these pre-existing risk factors as they often contribute significantly to clotting risk in this population
The Treatment Imperative: Effectively managing obesity is now recognized as a primary strategy to curb the rise of T2D and its life-threatening complications
Nature 504, 446450
My time in the diner with him was short but he held each of us so well, always going deep in convo and left me with lessons Ive carried with me in my career and teaching
Depending on eligibility and a providers prescription, the membership includes a range of options, from oral medications to injectable treatments, all delivered through an online care model
US$ 20.48
US$ 20.26
US$ 20.62
